CAR T-cell therapy shows promise for patients with myeloma – Healio
MedCity News |
CAR T-cell therapy shows promise for patients with myeloma
Healio Chimeric antigen receptor (CAR) T-cell therapies have demonstrated success in targeting B-cell biomarkers in clinical trials for acute lymphoblastic leukemia and lymphoma. However, there has been limited success with CAR T-cell therapies for targeting … CAR T-Cell therapy sends multiple myeloma into lasting remission Bluebird is pretty chirpy about its anti-BCMA CAR-T therapy results … bluebird bio and Celgene Corporation Announce Updated Clinical Results from Ongoing First-in-Human Multicenter … |
